Lupin submits copy of revised press release

01 Dec 2016 Evaluate

Lupin vide its letter dated December 01, 2016 has submitted a copy of Revised Press Release as regards expansion of partnership with Eli Lilly and Company (India) (Lilly), to market and sell Lillys rapid-acting Insulin analog Lispro under the brand name Eglucent.

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2151.05 19.25 (0.90%)
30-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1595.00
Dr. Reddys Lab 1218.40
Cipla 1323.95
Zydus Lifesciences 885.20
Lupin 2151.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×